Goldman Small Cap Research Publishes New Research Report on OKYO Pharma Limited
Portfolio Pulse from
Goldman Small Cap Research has published a new research report on OKYO Pharma Limited, highlighting its role in the ophthalmic drugs segment and providing a price target.
January 30, 2025 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Goldman Small Cap Research has published a new report on OKYO Pharma Limited, an emerging player in the ophthalmic drugs segment, and has set a price target.
The publication of a research report by Goldman Small Cap Research, which includes a price target, is likely to positively influence investor sentiment and potentially drive up the stock price of OKYO Pharma Limited in the short term. The report highlights OKYO's position in the growing ophthalmic drugs market, which could attract investor interest.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100